Stevanato Group S.p.A. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- STVNAccesswire • 06/04/24
Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and CartridgesBusiness Wire • 05/30/24
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroBusiness Wire • 05/28/24
Stevanato Group to Present at the Bank of America Securities Healthcare ConferenceBusiness Wire • 05/01/24
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire • 04/25/24
Stevanato Group (STVN) to Report Q1 Results: What You Should ExpectZacks Investment Research • 04/25/24
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary SharesBusiness Wire • 03/26/24
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesBusiness Wire • 03/22/24
Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumBusiness Wire • 03/11/24
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024Business Wire • 02/22/24
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationBusiness Wire • 01/24/24
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/03/24
Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingBusiness Wire • 11/16/23